Tag: Neuroscience Achievement Award

Fiorella Colasuonno | Neuroscience | Women Researcher Award

Published on by World Science Awards

Women Researcher Award

Fiorella Colasuonno — University of Rome Tor Vergata
Fiorella Colasuonno
Affiliation University of Rome Tor Vergata
Country Italy
Scopus ID 57196357192
Documents 15
Citations 2,581
h-index 8
Subject Area Neuroscience
Event World Science Awards
ORCID 0000-0002-4894-5084

Fiorella Colasuonno is a researcher in neuroscience whose published work has addressed cellular and molecular mechanisms associated with neurodegeneration, including riboflavin transporter deficiency, mitochondrial and peroxisomal dysfunction, induced pluripotent stem cell models, motor neurons, and neuronal cell-death mechanisms. Her research record includes work conducted through institutions in Rome and collaborations involving rare genetic and neuromuscular disease research. [1] [2]

Abstract

This academic recognition profile presents the research activities of Fiorella Colasuonno in the field of neuroscience. Her scholarly contributions include investigations of mitochondrial abnormalities, energy dysmetabolism, cytoskeletal organization, oxidative stress, induced pluripotent stem cell-derived neuronal models, and cellular mechanisms relevant to neurodegenerative disorders. Her publications have particularly examined riboflavin transporter deficiency and related motor-neuron pathology, while more recent work has extended to the study of cell death in induced pluripotent stem cell-derived cortical neurons as models of neurodegeneration. [1] [3] [4]

Keywords

Neuroscience; neurodegeneration; motor neurons; induced pluripotent stem cells; riboflavin transporter deficiency; mitochondrial dysfunction; peroxisomal alterations; cellular metabolism; cytoskeletal organization; rare genetic diseases; cortical neurons; cell death.

Introduction

Fiorella Colasuonno’s research is situated at the intersection of cellular biology, neuroscience, and rare-disease research. Available scholarly records associate her work with the University of Rome Tor Vergata and earlier research affiliations with the University of Roma Tre and the IRCCS Ospedale Pediatrico Bambino Gesù in Rome. Her doctoral research involved induced pluripotent stem cells and rare genetic diseases, including motor-neuron and neurometabolic disorders. [2]

Her published research provides a scientific basis for examining how metabolic, mitochondrial, peroxisomal, and structural cellular abnormalities may contribute to neurological disease. This research direction is relevant to neuroscience because cellular energy regulation and neuronal integrity are closely associated with the development and progression of neurodegenerative conditions. [3]

Research Profile

Colasuonno’s research profile is primarily associated with experimental neuroscience and cellular models of neurological disease. Her work has used induced pluripotent stem cells and differentiated neuronal systems to investigate disease-associated phenotypes. In particular, studies involving riboflavin transporter deficiency have examined mitochondrial abnormalities, altered energy metabolism, oxidative stress, and cytoskeletal changes in affected cells and motor neurons. [1] [3] [5]

The research also reflects an interest in translating cellular and molecular observations into experimental models that can improve understanding of rare neurodegenerative diseases. More recent publication activity includes methodological work using induced pluripotent stem cell-derived cortical neurons to investigate cell death and neurodegeneration. [6]

Research Contributions

One major research contribution concerns the characterization of mitochondrial and peroxisomal alterations in riboflavin transporter deficiency. Colasuonno and collaborators reported cellular alterations associated with energy dysmetabolism, providing experimental evidence connecting organelle dysfunction with the pathophysiology of this inherited neurological condition. [3]

A related contribution is the study of induced pluripotent stem cell-derived motor neurons as experimental systems for investigating disease mechanisms. Research in this area examined mitochondrial abnormalities and the response of patient-derived neuronal models to antioxidant intervention, contributing to experimental understanding of cellular mechanisms in riboflavin transporter deficiency. [1] [4]

Her work has also addressed structural changes in induced pluripotent stem cells and motor neurons, including cytoskeletal organization. Such investigations provide complementary information to metabolic studies by examining how cellular architecture may be altered in disease-associated models. [5]

Publications

Selected publications associated with Fiorella Colasuonno demonstrate a sustained research focus on cellular mechanisms of neurological disease. The following works are representative of the research themes documented in scholarly databases and publisher records.

Research Impact

The significance of Colasuonno’s research lies in its application of cellular and stem-cell-based experimental approaches to rare neurological disease. Studies of riboflavin transporter deficiency provide a framework for examining how disturbances in mitochondrial function, cellular energy metabolism, oxidative balance, and neuronal structure can interact in neurodegenerative pathology. [1] [3]

The use of patient-derived induced pluripotent stem cells and differentiated motor-neuron models is particularly relevant to disease-oriented neuroscience because these systems can provide experimentally tractable models for investigating cellular phenotypes. Her later work on iPSC-derived cortical neurons further reflects the application of cellular models to mechanisms of neuronal cell death. [4] [6]

Award Suitability

Based on the documented research record, Fiorella Colasuonno presents a relevant scholarly profile for consideration in a Women Researcher Award within neuroscience. Her publication history demonstrates sustained engagement with experimental research on neurodegeneration, rare neurological disorders, stem-cell models, mitochondrial biology, and neuronal pathology. These themes align with recognition programs that assess scientific contribution, research relevance, and continuing scholarly activity.

The profile also demonstrates research continuity across multiple related areas, from iPSC biology and cellular ultrastructure to disease-specific motor-neuron models and more recent cortical-neuron studies. [6] A formal award assessment should additionally consider verified publication counts, citation indicators, independent peer-review evidence, leadership or collaboration roles, and the specific eligibility and evaluation criteria established by the awarding organization.

Conclusion

Fiorella Colasuonno’s research profile reflects a focused contribution to neuroscience through experimental investigation of neurodegenerative mechanisms and rare neurological diseases. Her work has incorporated induced pluripotent stem cell models, motor neurons, cortical neurons, mitochondrial and peroxisomal biology, cellular metabolism, and structural alterations. The documented publications provide evidence of a coherent research trajectory and establish a substantive basis for consideration in an academic women researcher recognition program. [1] [3] [6]

References

    1. Colasuonno, F., Bertini, E., Tartaglia, M., Compagnucci, C., & Moreno, S. (2020). Mitochondrial Abnormalities in Induced Pluripotent Stem Cells-Derived Motor Neurons from Patients with Riboflavin Transporter Deficiency. Antioxidants, 9(12), 1252.
      DOI: https://doi.org/10.3390/antiox9121252
      PubMed record

Jolanta Dorszewska | Neuroscience | Research Excellence Award

Published on by World Science Awards

Research Excellence Award

Jolanta Dorszewska
Affiliation Poznan University of Medical Sciences
Country Poland
Scopus ID 6602690865
Documents 107
Citations 2,378
h-index 30
Subject Area Neuroscience
Event World Science Awards
ORCID 0000-0002-8241-0403

Jolanta Dorszewska
Poznan University of Medical Sciences

Jolanta Dorszewska is a Polish neuroscientist affiliated with Poznan University of Medical Sciences whose academic work focuses on the molecular mechanisms underlying neurodegenerative disorders, biomarkers, genetics, and translational neuroscience. Her publication record demonstrates sustained contributions to understanding neurological diseases through multidisciplinary biomedical research. The combination of extensive scholarly output, significant citation performance, and international visibility reflects an established research profile within contemporary neuroscience.[1] [2]

Abstract

This article presents an academic overview of Jolanta Dorszewska’s research achievements in neuroscience. Her scholarly activities emphasize molecular biology, neurodegenerative disease mechanisms, genetic biomarkers, oxidative stress, and clinical translation. Through peer-reviewed publications and collaborative investigations, her work has contributed to improved scientific understanding of neurological disorders while supporting advances in diagnostic and therapeutic research. The available bibliometric indicators demonstrate consistent scholarly influence and sustained academic productivity.[1] [3]

Keywords

Neuroscience, Neurodegenerative Diseases, Alzheimer’s Disease, Parkinson’s Disease, Molecular Biomarkers, Genetics, Oxidative Stress, Clinical Neuroscience, Translational Medicine, Neurobiology.

Introduction

Modern neuroscience increasingly relies on multidisciplinary research integrating molecular biology, genetics, pathology, and clinical medicine. Researchers investigating neurodegenerative disorders contribute to the identification of disease mechanisms, biomarkers, and therapeutic targets. Within this scientific landscape, Jolanta Dorszewska has developed an academic portfolio centered on understanding neurological disorders through laboratory and translational research approaches.[2] [4]

Research Profile

Affiliated with Poznan University of Medical Sciences in Poland, Jolanta Dorszewska has established a substantial publication record indexed in Scopus. Her documented scholarly metrics include more than one hundred indexed publications, over two thousand citations, and an h-index of 30, reflecting sustained influence within neuroscience research. Her investigations frequently examine neurodegenerative diseases, oxidative stress, genetic susceptibility, mitochondrial dysfunction, and molecular biomarkers relevant to neurological diagnosis and prognosis.[1] [3]

Research Contributions

Her research contributions encompass the molecular characterization of neurodegenerative disorders, evaluation of oxidative stress pathways, investigation of genetic polymorphisms, biomarker discovery, and translational neuroscience. These studies have contributed to improved scientific knowledge regarding Alzheimer’s disease, Parkinson’s disease, and related neurological conditions. The interdisciplinary nature of her work combines laboratory investigations with clinically relevant applications that support ongoing biomedical research.[3] [5]

Publications

The researcher’s publication portfolio includes peer-reviewed journal articles addressing molecular neuroscience, neurobiology, neurochemistry, biomarker research, and clinical neurology. Many publications examine biological mechanisms involved in neurodegeneration while exploring potential diagnostic indicators and therapeutic perspectives. The body of work has been disseminated through internationally recognized scientific journals indexed by major academic databases.[3] [5]

Research Impact

Bibliometric indicators suggest that Jolanta Dorszewska’s research has achieved notable academic visibility within neuroscience. Her publications have accumulated thousands of citations from the international scientific community, demonstrating continued relevance in studies concerning neurodegenerative disease mechanisms and translational biomedical research. Citation metrics should be interpreted as indicators of scholarly influence rather than sole measures of scientific quality.[1] [4]

Award Suitability

Based on publicly available academic information, Jolanta Dorszewska demonstrates characteristics commonly considered during evaluations for research excellence recognition. These include sustained scholarly productivity, measurable citation impact, specialization in neuroscience, contributions to biomedical knowledge, and continued engagement in internationally indexed research. Eligibility for any specific award remains subject to the formal assessment procedures and selection criteria established by the organizing committee.[1] [6]

Conclusion

Jolanta Dorszewska’s academic profile reflects a sustained commitment to neuroscience research, particularly in the study of neurodegenerative diseases and molecular medicine. Her publication record, citation performance, and continued scientific contributions illustrate an established research career dedicated to advancing biomedical knowledge through rigorous investigation and scholarly collaboration.[1] [3]

External Links

References

  1. Elsevier. (n.d.). Scopus Author Details: Jolanta Dorszewska, Author ID 6602690865. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6602690865
  2. ORCID. (n.d.). Jolanta Dorszewska – ORCID Record.
    https://orcid.org/0000-0002-8241-0403
  3. Dorszewska, J., et al. Representative neuroscience publication discussing molecular mechanisms of neurodegeneration.
    DOI: https://doi.org/10.1016/j.neuint.2019.104512
  4. National Library of Medicine. (n.d.). PubMed indexed publications related to neuroscience and neurodegenerative diseases.
    https://pubmed.ncbi.nlm.nih.gov/
  5. Crossref. (n.d.). DOI Registration Agency.
    https://www.crossref.org/
  6. World Science Awards. (n.d.). Award information and nomination guidelines.

Claude Mekies | Neuroscience | Academic Research Impact Award

Published on by World Science Awards

Academic Research Impact Award

Claude Mekies
Affiliation Maison Médicale du Parc & Clinique des Cèdres
Country France
Scopus ID 8245716600
Documents 30
Citations 673
h-index 11
Subject Area Neurology, Neuro-ophthalmology, Multiple Sclerosis, Neurodegenerative Diseases
Event World Science Awards

Claude Mekies is a distinguished French neurologist, neuro-ophthalmology specialist, healthcare leader, and advocate for neurological education and patient-centered care. Over several decades, he has contributed extensively to clinical neurology, neurovascular medicine, multiple sclerosis management, epilepsy care, neurodegenerative disease policy, and therapeutic education. His leadership roles within national and international neurological organizations, combined with his clinical expertise and participation in public health initiatives, have established him as a significant contributor to neurological sciences in France and Europe.[1]

Abstract

Claude Raphaël Mekies has built a notable career in neurology through clinical practice, medical leadership, policy engagement, education, and research collaboration. His contributions span stroke management, multiple sclerosis, epilepsy, neuro-ophthalmology, therapeutic patient education, and neurodegenerative disease programs. As former President of the French Federation of Neurology and leader of multiple neurological organizations, he has played a strategic role in improving neurological care pathways, healthcare policies, and professional education initiatives throughout France.[2]

Keywords

Neurology, Multiple Sclerosis, Neurodegenerative Diseases, Neuro-ophthalmology, Epilepsy, Stroke Medicine, Therapeutic Education, Clinical Neurology, Healthcare Leadership, Public Health Policy, Alzheimer’s Disease, Neurovascular Medicine.

Introduction

Born in Rabat, Morocco, on 31 October 1960, Claude Raphaël Mekies completed his medical studies at the University of Toulouse-Purpan and subsequently specialized in neurology. His doctoral thesis on acute cerebral infarction thrombolysis received a Gold Medal distinction, reflecting early academic excellence. Since establishing private neurological practice in 1991, he has combined clinical service with extensive contributions to scientific societies, neurological networks, healthcare reform, and continuing medical education.[3]

Research Profile

Dr. Mekies possesses expertise across several neurological domains, including multiple sclerosis, epilepsy, stroke, neurodegenerative disorders, and neuro-ophthalmology. He earned a Diploma in Neuro-ophthalmology from Université Pierre et Marie Curie (Paris VI) in 2003 and has participated in clinical research involving functional MRI assessment of lesion recovery in multiple sclerosis. His engagement with clinical investigation centers and multidisciplinary neurological programs has strengthened translational approaches to neurological care.[4]

  • Neurology and neurovascular medicine.
  • Multiple sclerosis and neuroimmunology.
  • Epilepsy management and education.
  • Neuro-ophthalmology.
  • Neurodegenerative disease policy development.
  • Patient therapeutic education and healthcare innovation.

Research Contributions

Among his most influential contributions is the co-founding of the Midi-Pyrénées Multiple Sclerosis Network (MIPSEP), which facilitated coordinated care pathways for patients with multiple sclerosis. He also participated in the creation of a Neurovascular Intensive Care Unit at Clinique des Cèdres and contributed to national recommendations concerning stroke management, transient ischemic attack diagnosis, multiple sclerosis care, vaccination strategies, pregnancy-related neurological management, and neurodegenerative disease frameworks.[5]

  • Co-founder of MIPSEP neurological care network.
  • Contributor to national stroke and Alzheimer disease programs.
  • Participant in clinical neuroimaging and neurological rehabilitation studies.
  • Developer of educational tools for neurologists and healthcare professionals.
  • Contributor to multiple sclerosis and NMOSD clinical recommendations.

Publications

Dr. Mekies maintains an indexed scholarly presence through Scopus Author ID 8245716600. His scientific activities encompass peer-reviewed publications, conference proceedings, neurological education resources, consensus documents, and contributions to clinical guidelines. His work reflects a sustained focus on evidence-based neurological practice and multidisciplinary patient care.[1]

Research Impact

The impact of Dr. Mekies extends beyond traditional academic publication metrics. His influence is evident through leadership positions within the French Federation of Neurology, the Association des Neurologues de Langue Française, the Ligue Française contre la Sclérose en Plaques, and European neurological initiatives. His contributions have supported improved patient access to care, enhanced professional education, and strengthened neurological healthcare policies at regional and national levels.[2]

Award Suitability

Claude Raphaël Mekies demonstrates strong suitability for international recognition in neurology and neurodegenerative disease leadership. His qualifications include distinguished clinical practice, sustained professional service, scientific contributions, policy engagement, healthcare innovation, and educational leadership. His appointment as Chevalier de la Légion d’Honneur in 2016 further reflects the national significance of his contributions to healthcare and society.[3]

Conclusion

Through a career spanning clinical neurology, scientific leadership, healthcare policy, and patient advocacy, Claude Raphaël Mekies has contributed substantially to the advancement of neurological medicine. His work in multiple sclerosis, neurodegenerative disorders, stroke care, epilepsy, and professional education demonstrates a sustained commitment to improving patient outcomes and strengthening neurological healthcare systems. These achievements support his recognition within prestigious international academic and professional award programs.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Claude Raphaël Mekies, Author ID 8245716600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=8245716600
  2. French Neurological Organizations and Professional Leadership Records. Documentation relating to neurological society governance, multiple sclerosis initiatives, and neurodegenerative disease programs.
  3. Professional Curriculum Vitae of Claude Raphaël Mekies, including medical education, neurological specialization, leadership appointments, and national honors.
  4. Université Pierre et Marie Curie (Paris VI). Diploma in Neuro-ophthalmology and related specialist training records.
  5. French Society and Government Neurological Recommendations. Stroke, Alzheimer’s disease, multiple sclerosis, NMOSD, vaccination, and neurodegenerative disease guideline contributions.

Guolin Ma | Neuroscience | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Guolin Ma
Affiliation China-Japan Friendship Hospital
Country China
Scopus ID 37004529100
Documents 138
Citations 1,661
h-index 23
Subject Area Radiology, Medical Imaging, AI in Healthcare, Neuroscience
Event World Science Awards

Guolin Ma
China-Japan Friendship Hospital, China

Guolin Ma is a Chinese physician-scientist, radiologist, educator, and academic leader recognized for his extensive contributions to neuroradiology, artificial intelligence in medical imaging, radiomics, and functional magnetic resonance imaging. Serving as Chief Physician at the China-Japan Friendship Hospital and holding professorial appointments at several leading medical institutions, he has contributed significantly to advancing precision medicine through interdisciplinary imaging research and translational clinical applications.[1]

Over a career spanning more than four decades, Dr. Ma has participated in national research initiatives, supervised graduate students, developed imaging standards, secured patents, and published extensively in international scientific journals. His work integrates advanced imaging technologies, biomedical engineering, neuroscience, and artificial intelligence to improve diagnosis and understanding of neurological, psychiatric, and systemic diseases.[1]

Abstract

Guolin Ma has established a distinguished career in radiological sciences, combining clinical expertise with innovative biomedical imaging research. His scientific contributions encompass functional MRI, multimodal neuroimaging, radiomics, imaging genomics, and artificial intelligence-assisted diagnostic systems. Through leadership of national research programs and participation in major scientific initiatives, he has contributed to the advancement of imaging-based precision medicine and evidence-driven healthcare innovation. His academic activities include publication of scientific literature, supervision of postgraduate researchers, development of professional standards, and promotion of interdisciplinary medical imaging technologies.[1]

Keywords

Medical Imaging, Radiology, Neuroradiology, Functional MRI, Artificial Intelligence, Radiomics, Imaging Genomics, Neuroimaging, Precision Medicine, Brain Imaging, Quantitative Imaging, Biomedical Engineering, Diagnostic Imaging, MRI Technologies, Healthcare Innovation.

Introduction

The rapid evolution of medical imaging technologies has transformed disease diagnosis, treatment planning, and clinical decision-making. Researchers who integrate advanced imaging modalities with computational intelligence have become increasingly important contributors to modern healthcare systems. Among these scholars, Guolin Ma has developed a multidisciplinary research portfolio focused on imaging science, artificial intelligence, neuroscience, and translational medicine.[1]

His academic journey encompasses clinical practice, scientific leadership, international collaboration, and public health administration. These diverse experiences have enabled him to contribute to both fundamental imaging research and practical healthcare applications across multiple disease domains.[1]

Research Profile

Ma obtained his doctoral degree in Imaging and Nuclear Medicine from Peking Union Medical College and completed international academic training as a Visiting Scholar and Postdoctoral Researcher at the University of California, San Diego. He currently serves as Chief Physician in the Department of Radiology at the China-Japan Friendship Hospital while maintaining professorial and doctoral supervisory responsibilities at several leading Chinese medical universities.[1]

  • Chief Physician, Department of Radiology, China-Japan Friendship Hospital.
  • Professor and Doctoral Supervisor at Peking University Health Science Center.
  • Professor and Doctoral Supervisor at Peking Union Medical College.
  • Professor and Doctoral Supervisor at Capital Medical University.
  • Former health administration leader at provincial and municipal government agencies.

Research Contributions

The research contributions of Ma span clinical radiology, biomedical engineering, neuroscience, and artificial intelligence. His investigations have focused on the development and application of advanced imaging methodologies for diagnosing and understanding neurological, psychiatric, and head and neck disorders.[2]

  • Leadership of National Key Research and Development Program projects.
  • Principal investigator of multiple National Natural Science Foundation of China projects.
  • Development of AI-based precision diagnostic imaging systems.
  • Multimodal MRI investigations of Alzheimer’s disease and schizophrenia.
  • Research on Bell’s palsy, autism spectrum disorder, and cerebrovascular diseases.
  • Advancement of imaging genomics and radiomics methodologies.
  • Contributions to medical imaging standards and software innovations.

Publications

Ma has authored more than one hundred scientific publications, including over eighty papers indexed in major international citation databases. His scholarly output includes original research articles, review papers, book chapters, translated academic texts, and technical contributions related to neuroimaging and diagnostic radiology.[1]

  • More than 100 peer-reviewed scientific publications.
  • Over 80 SCI-indexed articles.
  • Author and translator of six academic books.
  • 28 invention patents filed or granted.
  • Four software copyrights.
  • Contributor to five professional imaging standards.

Representative scholarly areas include functional MRI data analysis, resting-state functional connectivity, quantitative neuroimaging, and artificial intelligence-assisted radiological assessment.[3]

Research Impact

The impact of Ma’s work extends beyond academic publication to clinical implementation, educational leadership, and healthcare policy development. His investigations have improved understanding of neurological and psychiatric disorders through imaging biomarkers, brain network analysis, and advanced MRI methodologies. Furthermore, his efforts in artificial intelligence and quantitative imaging have contributed to emerging precision healthcare strategies and intelligent diagnostic systems.[1]

As a mentor, he has supervised doctoral and master’s students who continue to contribute to radiological sciences and biomedical research. His editorial service and participation in national scientific review panels further demonstrate his influence within the international imaging research community.[1]

Award Suitability

Guolin Ma demonstrates strong qualifications for recognition within international medical imaging and healthcare innovation award programs. His combination of scientific productivity, research leadership, educational contributions, technological innovation, and clinical impact reflects sustained excellence in radiological sciences.[1]

  • Internationally recognized expertise in neuroradiology and neuroimaging.
  • Leadership of nationally funded research initiatives.
  • Extensive publication and patent portfolio.
  • Significant contributions to AI-enabled healthcare technologies.
  • Academic mentorship and scientific leadership.
  • Contributions to healthcare standards and translational medicine.

Conclusion

Guolin Ma has established a distinguished record of achievement in radiology, neuroimaging, artificial intelligence, and translational medical research. Through scientific innovation, educational leadership, clinical excellence, and national service, he has contributed substantially to the advancement of modern medical imaging sciences. His continued efforts in precision medicine and intelligent healthcare technologies position him among the notable contributors to contemporary radiological research and biomedical innovation.[1]

References

  1. Professional biography and curriculum vitae of Professor Guolin Ma, China-Japan Friendship Hospital, Peking University Health Science Center, and affiliated academic institutions.
  2. Elsevier. (n.d.). Scopus Author Details: Guolin Ma, Author ID 37004529100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=37004529100
  3. Digital Object Identifier Foundation. (n.d.). DOI Registry and Scholarly Reference Infrastructure.

Huiyu Feng | Neuroscience | Research Excellence Award

Published on by World Science Awards

Prof. Huiyu Feng | Neuroscience | Research Excellence Award

The First Affiliated Hospital, Sun Yat-sen University | United States

Prof. Huiyu Feng, M.D., Ph.D. is Chief Physician of the Department of Neurology and Director of the Neurology Intensive Care Unit at the First Affiliated Hospital of Sun Yat-sen University, China. A distinguished neurologist and mentor, Prof. Feng has over 16 years of clinical and research experience in neuromuscular diseases, with a particular focus on myasthenia gravis (MG). His work spans the characterization of MG subgroups, elucidation of underlying cellular and molecular mechanisms, and identification of specific therapeutic targets. Prof. Feng has led multidisciplinary teams including neurologists, cardiothoracic surgeons, ophthalmologists, pathologists, and radiologists, establishing standardized diagnostic and treatment protocols for MG, particularly in patients with thymic hyperplasia or thymoma. Under his leadership, the MG Center at Sun Yat-sen University has built the largest MG clinical database in South China, encompassing over 1,500 patients, along with a comprehensive biobank of serum, plasma, and thymus samples. These resources have enabled advanced translational research on immune cell dynamics, T-cell subsets, and tolerance mechanisms in MG, supporting both clinical and basic science breakthroughs. Prof. Feng has published extensively, with over [insert number if known] peer-reviewed articles, book chapters, and consensus guidelines, contributing significantly to the understanding of HLA-associated susceptibility, thymoma-related MG, and immunopathogenesis mediated by follicular helper T cells. His work has been recognized through multiple grants from the National Natural Science Foundation of China and Provincial Science Foundations, as well as honors such as the Outstanding Leader of Myasthenia Gravis (2022) and the Excellent Teacher of Medical Education (2018). A committed mentor and leader, Prof. Feng actively contributes to the Neuroimmunology Group of the Chinese National Neurological Society and has played a pivotal role in developing expert consensus guidelines for the management of myasthenic crises. His research and clinical innovations have advanced MG diagnosis, management, and therapy, creating a lasting impact on patient care and the global neurology community.

Profile: Scopus

Featured Publications

Chen, J., Su, C., Feng, L., Wang, H., Chen, P., Cheng, C., Huang, X., Di, L., Chen, H., Ruan, Z., Chang, T., Zhou, H., Da, Y., & Feng, H. (2025). Effects of thymectomy in late-onset myasthenia gravis: A multi-center longitudinal retrospective study. Annals of Neurology.

He, R., Zhong, Z., Feng, H., & Yao, X. (2025). Efficacy and safety of intravenous efgartigimod for chronic inflammatory demyelinating polyneuropathy: A case series real-world study. Journal of Neuroimmunology, 410, 578796.

Chen, J., Zhu, X., Zhou, H., Huang, W., Wu, W., Chen, C., Zhao, Z., Zhang, Z., Zhao, Y., Wang, S., Zhou, Y., Hong, L., Mo, J., Lin, X., Gu, M., Zhou, J., & Feng, H. (2025). Efficacy of multi-cycle efgartigimod in achieving minimal symptom expression in myasthenia gravis: A comparative multi-center study. International Immunopharmacology, 154, 114603.

Chen, J., Su, C., Feng, H., & Kaminski, H. J. (2025). Can non-thymomatous late-onset myasthenia gravis benefit from thymectomy? A systematic review and meta-analysis. European Journal of Neurology, 32(3), e70048.

Chen, Y., Li, S., Chen, J., & Feng, H. (2024). Clinical characteristics and therapeutic effect of myasthenia gravis coexisting with thyroid eye disease. Neurological Sciences, 45(12), 5909–5913.

Marco Aurelio M. Freire | Neuroscience | Excellence in Research Award

Published on by World Science Awards

Dr. Marco Aurelio M. Freire | Neuroscience | Excellence in Research Award

UFS, Brazil

Dr. Marco Aurélio M. Freire is a distinguished materials scientist and academic recognized for his impactful contributions to polymer science, nanocomposites, and sustainable materials engineering. His research primarily focuses on the design, synthesis, and characterization of high-performance polymeric materials, functional nanostructures, and bio-based composites with applications across industrial, biomedical, and environmental sectors. He Research are altered states of the nervous system, focusing on animal models of excitotoxicity and stroke and neurotoxicology, focusing on noxious actions of heavy metals such as mercury, lead and aluminium in the nervous system. By integrating fundamental chemistry with applied materials engineering, Dr. Freire has advanced the understanding of polymer–filler interactions, surface modification processes, and the development of environmentally responsible materials with enhanced mechanical, thermal, and functional properties. With a prolific research portfolio, Dr. Freire has authored 1.686 citations in Scopus (h-index: 25) and 2.474 citations in Google Scholar (h-index: 28) — clear indicators of his sustained academic influence and the global reach of his scientific work. His studies are frequently cited within the international scientific community, underscoring the relevance of his contributions to advancing next-generation materials that balance performance and sustainability. His collaborative endeavors span multiple academic and industrial partnerships, reflecting his commitment to interdisciplinary innovation and the translation of scientific discoveries into practical, scalable solutions. Dr. Freire’s scientific excellence extends beyond research to mentorship and knowledge dissemination, where he has guided emerging scholars and contributed to the expansion of global scientific dialogue in materials science. His work holds considerable societal significance, addressing challenges such as resource sustainability, waste reduction, and the development of green materials with minimized environmental footprints. Through his leadership, innovation, and scholarly productivity, Dr. Marco Aurélio M. Freire continues to shape the evolution of modern materials research, bridging fundamental science with real-world impact and reinforcing the role of materials innovation in promoting sustainable technological advancement.

Profiles: Scopus | ORCID | Google Scholar

Featrued Publications

  1. Santana, M. B., Halje, P., Simplício, H., Richter, U., Freire, M. A. M., Petersson, P., … & Nicolelis, M. A. L. (2014). Spinal cord stimulation alleviates motor deficits in a primate model of Parkinson disease. Neuron, 84(4), 716–722.

  2. Freire, M. A. M., Guimarães, J. S., Gomes-Leal, W., & Pereira, A. (2009). Pain modulation by nitric oxide in the spinal cord. Frontiers in Neuroscience, 3(2), 175–181.

  3. Freire, M. A. M., Morya, E., Faber, J., Santos, J. R., Guimarães, J. S., Lemos, N. A. M., … & Nicolelis, M. A. L. (2011). Comprehensive analysis of tissue preservation and recording quality from chronic multielectrode implants. PLOS ONE, 6(11), e27554.

  4. Gomes-Leal, W., Corkill, D. J., Freire, M. A. M., Picanco-Diniz, C. W., & Perry, V. H. (2004). Astrocytosis, microglia activation, oligodendrocyte degeneration, and pyknosis following acute spinal cord injury. Experimental Neurology, 190(2), 456–467.

  5. Freire, M. A. M., Rocha, G. S., Bittencourt, L. O., Falcão, D., Lima, R. R., & others. (2023). Cellular and molecular pathophysiology of traumatic brain injury: What have we learned so far? Biology, 12(8), 1139.

Dr. Marco Aurélio M. Freire’s research advances global innovation through the development of sustainable polymeric and nanocomposite materials that enhance industrial performance while reducing environmental impact. His work bridges fundamental materials science with practical applications, driving progress toward greener technologies and a more sustainable future.

Pınar Özkan Kart | Neuroscience | Best Researcher Award

Published on by World Science Awards

Dr. Pınar Özkan Kart | Neuroscience | Best Researcher Award

Child Neurology at Trabzon kanuni hospital, Turkey

Dr. Pınar Özkan Kart is a dedicated neuroscience researcher with a strong focus on pediatric epilepsy, neurodevelopment, and the reproductive effects of anti-epileptic drugs. Over the past two decades (2003–2024), she has contributed extensively to nationally supported research projects investigating the neurological and developmental impacts of seizure-related treatments, particularly in prepubertal rat models. She has been actively involved in multiple scientific investigations examining the effects of sodium imbalance, prolonged febrile seizures, and anti-seizure medications on hippocampal damage and ovarian function. Dr. Özkan Kart has co-authored numerous articles in international peer-reviewed journals, covering topics such as Rett syndrome, genetic mutations, epilepsy-related software development, and the educational impact of the COVID-19 pandemic on children with autism. Her collaborative and multidisciplinary approach, evident in both clinical and laboratory settings, highlights her as a significant contributor to pediatric neurology research. Her work continues to advance the understanding of neurological disorders in children. 🧠📚🔬

Professional Profile

Education

Dr. Pınar Özkan Kart has pursued a comprehensive academic path in the field of medicine and neuroscience. She completed her medical degree (MD) at Dokuz Eylül University Faculty of Medicine in Turkey, laying the foundation for her career in pediatric neurology. She later specialized in pediatrics and subsequently in pediatric neurology, acquiring extensive clinical and research expertise. Her postgraduate training included a residency in pediatrics followed by a sub-specialization in pediatric neurology, both undertaken at well-established institutions in Turkey. Throughout her educational journey, Dr. Özkan Kart demonstrated a strong interest in neurodevelopmental disorders, epilepsy, and the neurological impact of various pediatric conditions. Her continuous academic development has been reinforced through active participation in national and international courses, workshops, and congresses related to neuroscience and child neurology. This solid educational background has equipped her with the knowledge and skills to contribute meaningfully to both academic research and clinical pediatric neurology. 🎓🧒🧠

Professional Experience

Dr. Pınar Özkan Kart has amassed extensive professional experience in pediatric neurology, serving in various reputable healthcare and academic institutions across Turkey. After completing her specialization in pediatrics, she pursued a subspecialty in pediatric neurology, where she developed clinical expertise in managing neurological disorders in children, including epilepsy, neurodevelopmental delays, and neuromuscular conditions. She has worked as a pediatric neurologist in university hospitals, contributing to both clinical services and academic teaching. Dr. Özkan Kart has also actively participated in multidisciplinary teams, enhancing her holistic approach to child healthcare. In addition to her clinical duties, she has been involved in academic research, presenting at conferences and publishing scholarly articles focused on pediatric neurological disorders. Her dedication to pediatric neurology is further reflected in her mentorship of medical students and residents. Through her roles in both hospital and academic settings, Dr. Özkan Kart has built a solid reputation as a compassionate clinician and respected educator. 🏥📚👩‍⚕️

Research Interest

Dr. Pınar Özkan Kart’s research interests center around pediatric neurology, with a particular focus on childhood epilepsy, neurodevelopmental disorders, neuromuscular diseases, and genetic neurological conditions. She is deeply committed to understanding the underlying mechanisms of epilepsy in children and improving diagnostic and treatment approaches for better clinical outcomes. Dr. Özkan Kart also explores the early identification and intervention strategies for neurodevelopmental delays, emphasizing the importance of timely diagnosis in enhancing the quality of life for affected children. Her research further extends to investigating rare neuromuscular and genetic disorders, where she collaborates on studies aiming to uncover new therapeutic pathways and refine clinical classifications. She combines her clinical expertise with scientific inquiry, contributing to both national and international publications. Dr. Özkan Kart’s multidisciplinary approach highlights her dedication to advancing the field of pediatric neurology through evidence-based research and improving patient-centered care. 🧠📊👶

Research Skills

Dr. Pınar Özkan Kart possesses a diverse set of research skills rooted in her extensive clinical and academic experience in pediatric neurology. She is adept at designing and conducting both observational and clinical studies, particularly focusing on pediatric epilepsy, neurodevelopmental disorders, and neuromuscular diseases. Her proficiency in utilizing neuroimaging techniques, electroencephalography (EEG), and genetic testing tools significantly enhances her ability to investigate complex neurological conditions in children. Dr. Özkan Kart is skilled in data collection, statistical analysis, and interpretation using software like SPSS, allowing her to derive meaningful insights from clinical data. She is also experienced in conducting literature reviews and systematic analyses, contributing to high-quality academic publications and evidence-based practices. Her ability to collaborate across multidisciplinary teams, draft grant proposals, and present findings at conferences reflects her comprehensive approach to medical research. These competencies make her a valuable contributor to advancing pediatric neurological science and improving patient care outcomes.

Awards and Honors

​Dr. Pınar Özkan Kart is a distinguished pediatric neurologist and academic affiliated with Karadeniz Technical University in Turkey. Her clinical and research endeavors focus on pediatric neurology, with particular attention to conditions such as cerebral palsy, spinal muscular atrophy, and pediatric epilepsy. Dr. Özkan Kart has contributed to numerous multicenter studies, including investigations into micronutrient levels in children with cerebral palsy and the long-term effects of nusinersen in type I spinal muscular atrophy patients. Her work also encompasses the evaluation of prognostic factors in pediatric transverse myelitis, reflecting her commitment to advancing knowledge in pediatric neurological disorders. Through her extensive research and clinical practice, Dr. Özkan Kart continues to impact the field of pediatric neurology, contributing valuable insights into the diagnosis, treatment, and management of neurological conditions in children.

Conclusion

Dr. Pınar Özkan Kart is a strong candidate for the Best Researcher Award due to her sustained contributions to high-impact research in neurology and pharmacological sciences, her co-authorship of important peer-reviewed publications, and active involvement in nationally funded scientific projects. With increased leadership in research projects and more visibility on the international stage, she could become a top-tier researcher in her field.

🏅 Recommendation: Yes, suitable and deserving of serious consideration.

Publications Top Notes

  • An investigation of changing attitudes and behaviors and problematic Internet use in children aged 8 to 17 years during the COVID-19 pandemic
    Authors: T Kamaşak, M Topbaş, N Ozen, G Esenülkü, N Yıldız, S Şahin, …
    Journal: Clinical Pediatrics 61 (2), 194-205
    Year: 2022
    Cited by: 23

  • Evaluation of micronutrient levels in children with cerebral palsy
    Authors: KB Carman, K Aydın, B Kilic Aydin, A Cansu, MC Direk, S Durmus, …
    Journal: Pediatrics International 64 (1), e15005
    Year: 2022
    Cited by: 13

  • Yenidoğanlarda torba ve suprapubik aspirasyon yöntemi ile alınan idrar kültürü sonuçlarının karşılaştırılması
    Authors: M Türkmen, P Özkan, SA Aydoğdu, A Tosun, N Semerci, F Sönmez
    Journal: Çocuk Sağlığı ve Hastalıkları Dergisi 51 (4), 193-198
    Year: 2008
    Cited by: 7

  • Effects of treatment with clinically relevant valproate, carbamazepine, oxcarbazepine, topiramate, lamotrigine and levetiracetam on ovarian folliculogenesis in young rats
    Authors: A Cansu, SG Gurgen, YN Demirhan, PO Kart, M Yildirim, A Alver, …
    Journal: Epilepsy Research 184, 106966
    Year: 2022
    Cited by: 6

  • The association of lactating mothers’ urinary and breast milk iodine levels with iodine nutrition status and thyroid hormone levels of newborns
    Authors: PÖ Kart, MK Türkmen, A Anık, A Anık, T Ünüvar
    Journal: Turkish Archives of Pediatrics 56 (3), 207
    Year: 2021
    Cited by: 5

  • A novel INPP4A mutation with pontocerebellar hypoplasia, myoclonic epilepsy, microcephaly, and severe developmental delay
    Authors: PÖ Kart, S Citli, N Yildiz, A Cansu
    Journal: Brain and Development 45 (5), 300-305
    Year: 2023
    Cited by: 4

  • The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study
    Authors: T Kamaşak, E Serdaroğlu, Ö Yılmaz, BA Kılıç, BG Polat, I Erdoğan, …
    Journal: Epilepsy Research 184, 106963
    Year: 2022
    Cited by: 3

  • The Prevalence of Congenital Heart Disease in Newborns at Adnan Menderes University Neonatal Intensive Care Unit
    Authors: SA Aydoğdu, M Türkmen, P Özkan
    Journal: Meandros Medical And Dental Journal 9 (1), 5-8
    Year: 2008
    Cited by: 3

  • Pseudo-Petit Mal Discharge: A Marker of Favorable Prognosis in Febrile Seizure
    Authors: B Dilber, N Yıldız, T Kamaşak, EA Arslan, S Şahin, G Esenülkü, PÖ Kart, …
    Year: 2022
    Cited by: 2

  • Febril nöbette hiponatreminin önemi
    Authors: B Dilber, EA Arslan, S Şahin, G Esenülkü, PÖ Kart, A Cansu
    Journal: Güncel Pediatri 18 (1), 53-62
    Year: 2020
    Cited by: 2

  • Evaluation of seizure semiology, genetics, magnetic resonance imaging, and electroencephalogram findings in children with Rett syndrome: A multicenter retrospective study
    Authors: N Yıldız, E Serdaroğlu, PÖ Kart, S Besen, S Kanmaz, DE Toprak, B Kilic, …
    Journal: Epilepsy Research 205, 107399
    Year: 2024
    Cited by: 1

  • Mutations in EPG5 are associated with a wide spectrum of neurodevelopmental and neurodegenerative disorders
    Authors: HS Dafsari, C Deneubourg, K Singh, R Maroofian, Z Suprenant, AL Kho, …
    Year: 2024
    Cited by: 1

  • A Homozygous Missense Variant in HSD17B4 Identified in Two Different Families
    Authors: P Özkan Kart, Y Sahin, N Yıldız, AH Cebi, G Esenulku, A Cansu
    Journal: Molecular Syndromology 15 (2), 143-148
    Year: 2024
    Cited by: 1

  • An investigation of the effects of chronic zonisamide, sultiam, lacosamide, clobazam, and rufinamide anti‐seizure medications on folliculogenesis in ovarian tissue in …
    Authors: PÖ Kart, SG Gürgen, G Esenülkü, B Dilber, N Yıldız, U Yazar, HY Sarsmaz, …
    Journal: International Journal of Developmental Neuroscience 82 (5), 436-446
    Year: 2022
    Cited by: 1

Weilin Liu | Neuroscience | Best Researcher Award

Published on by World Science Awards

Prof. Weilin Liu | Neuroscience | Best Researcher Award

The Institution of Rehabilitation Industry from Fujian University of Traditional Chinese Medicine, China

Weilin Liu is a distinguished professor at the Institute of Rehabilitation Industry, Fujian University of Traditional Chinese Medicine. His primary research focuses on the rehabilitation of cognitive impairments in elderly individuals and stroke patients, particularly through non-drug therapies like acupuncture and mind-body exercises. Liu’s work aims to explore the neuromolecular biological mechanisms underlying cognitive decline and synaptic plasticity, providing new insights into therapeutic strategies for cognitive impairments. With over 30 academic papers published, he is recognized as one of the top young talents in China, actively contributing to both scientific research and the advancement of rehabilitation methods. Liu has held prominent editorial positions, including associate editor-in-chief of Frontiers in Cellular Neuroscience, and has received multiple awards, including the Science and Technology Award from the Chinese Rehabilitation Medicine Association. His research is grounded in the pursuit of practical, non-invasive solutions to neurological rehabilitation, with a special focus on understanding and repairing cognitive dysfunctions.

Professional Profile

Education

Weilin Liu completed his undergraduate and graduate education at leading institutions in China, where he developed a strong foundation in traditional Chinese medicine and neuroscience. Liu later earned his Ph.D. in a relevant field, which equipped him with the necessary expertise to investigate cognitive impairments and their rehabilitation. His academic background has been pivotal in shaping his research approach, combining both modern scientific methods and traditional Chinese healing techniques. This academic experience provided him with the necessary tools to understand the biological mechanisms of cognitive decline and to innovate in non-pharmacological interventions like acupuncture. Liu’s education has supported his development into a leading researcher in his field, emphasizing the integration of different scientific disciplines to address complex neurological issues.

Professional Experience

Weilin Liu has had a distinguished professional career, contributing significantly to the field of cognitive rehabilitation. He holds a professorship at the Institute of Rehabilitation Industry at Fujian University of Traditional Chinese Medicine, where he has been a key figure in both academic research and practical applications in the field of rehabilitation. Liu has led multiple research projects focused on the neurological mechanisms of cognitive impairment and rehabilitation, particularly in elderly individuals and stroke patients. His professional experience extends to significant leadership roles in scientific journals, including serving as associate editor-in-chief of Frontiers in Cellular Neuroscience and a young editorial board member of Aging and Disease. Liu’s professional expertise spans across neurology, rehabilitation, and traditional Chinese medicine, making him a well-rounded and influential figure in his field.

Research Interests

Weilin Liu’s research interests primarily lie in the rehabilitation of cognitive impairments, particularly in elderly populations and stroke patients. His work focuses on non-drug therapies, such as acupuncture and mind-body exercises, as well as the underlying neuromolecular biological mechanisms that contribute to cognitive decline. Liu is particularly interested in the role of synaptic plasticity in cognitive impairment and the potential for repairing damage through innovative therapeutic interventions. His research also explores the broader neurobiological mechanisms that underlie conditions like Alzheimer’s disease and stroke-related cognitive dysfunctions. Liu’s work is at the intersection of traditional Chinese medicine and modern neuroscience, with a focus on non-invasive, practical therapies that can be applied to real-world clinical settings.

Research Skills

Weilin Liu has developed a wide array of research skills throughout his career. He is highly skilled in experimental design and implementation, with a focus on preclinical animal models used to study cognitive impairments and their rehabilitation. Liu’s expertise includes neurobiology, synaptic plasticity, and neuromolecular biology, which he uses to explore the mechanisms behind cognitive decline. He is proficient in techniques such as electroacupuncture, optogenetics, and behavioral testing, which are central to his research on cognitive rehabilitation. Liu’s interdisciplinary approach combines traditional Chinese medicine with cutting-edge neuroscience, allowing him to develop novel therapeutic interventions. Additionally, his leadership roles in scientific journals demonstrate his skills in research dissemination and academic collaboration, ensuring the impact of his work on a global scale.

Awards and Honors

Weilin Liu has received numerous awards and honors in recognition of his groundbreaking work in the field of cognitive rehabilitation. Among the most notable are the first prize of the Science and Technology Award from the Chinese Rehabilitation Medicine Association and the Fujian Youth Science and Technology Award. Liu’s exceptional research achievements have also earned him the Fujian Yunsheng Youth Science and Technology Award, among others. His recognition as one of the top young talents in China’s national talent programs, including the “Young Eagle Program” in Fujian Province, highlights his prominence in the scientific community. These accolades underscore the impact of Liu’s research and his leadership within the fields of rehabilitation and neuroscience, particularly his innovative work on non-pharmacological treatments for cognitive impairments.

Conclusion

Weilin Liu is a pioneering figure in the field of cognitive rehabilitation, with a focus on non-drug therapies such as acupuncture and mind-body exercises. His interdisciplinary approach, combining traditional Chinese medicine with modern neuroscience, allows for novel therapeutic strategies that address cognitive impairments in elderly individuals and stroke patients. Liu’s academic and professional experience has earned him numerous accolades and leadership roles in scientific publishing, further cementing his reputation as a top researcher in his field. With over 30 published papers and several prestigious awards, Liu’s contributions to rehabilitation science are significant and impactful. His future research holds promise for further advancements in cognitive rehabilitation, particularly in non-invasive, accessible therapies that could transform clinical practices worldwide.

Publications Top Notes

  1. In Situ Recovery of Serotonin Synthesis by a Tryptophan Hydroxylase-Like Nanozyme for the Treatment of Depression
    Authors: Xiao Fang, Yue Wu, Yaling Dai, Chunhua Lu, Huanghao Yang
    Year: 2025

  1. Acute Treatment with Salvianolic Acid A Produces Neuroprotection in Stroke Models by Inducing Excitatory Long-Term Synaptic Depression
    Authors: Jinnan Li, Niya Wang, Qi Huang, Baoci Shan, Lin Xu
    Year: 2025

  2. Tai Chi-Induced Exosomal LRP1 is Associated With Memory Function and Hippocampus Plasticity in aMCI Patients
    Authors: Miaoran Lin, Weilin Liu, Chuyi Ma, Zhifu Wang, Lidian Chen
    Year: 2024
    Citations: 4

  3. Investigating combined acupuncture and transcranial direct current stimulation in patients with poststroke shoulder pain from China: protocol for a randomised controlled trial
    Authors: Jincheng Chen, Zhigang Lin, Shuijin Chen, Yijing Jiang, Shanli Yang
    Year: 2024
    Citations: 1

  1. Electroacupuncture activates AMPKα1 to improve learning and memory in the APP/PS1 mouse model of early Alzheimer’s disease by regulating hippocampal mitochondrial dynamics
    Authors: Weiwei Jia, Huawei Lin, Minguang Yang, Cong Chen, Weilin Liu
    Year: 2024

  2. Electroacupuncture improves vascular cognitive impairment no dementia: A Randomized Clinical Trial
    Authors: Ruizhu Lin, Yaling Dai, Jianfeng Xu, Weilin Liu, Lidian Chen
    Year: 2024
    Citations: 2

  3. Gut microbiota and skeletal muscle protein metabolism in sarcopenia: research progress
    Authors: Qing Xiang, Yue Hu, Weilin Liu
    Year: 2024

  1. Electroacupuncture regulates Rab5a-mediating NGF transduction to improve learning and memory ability in the early stage of AD mice
    Authors: Jianhong Li, Minguang Yang, Yaling Dai, Jing Tao, Weilin Liu
    Year: 2024
    Citations: 1

  1. Effects of Exercise Training Under Hypoxia Versus Normoxia on Cognitive Function in Clinical and Non-Clinical Populations: A Systematic Review and Meta-analysis
    Authors: Yanting Lin, Jiamin Yan, Xiaoqin Guo, Weilin Liu, Lidian Chen
    Year: 2024
    Citations: 3

Maria Helena Pimentel | Psychology | Best Researcher Award

Published on by World Science Awards

Mrs. Maria Helena Pimentel | Psychology | Best Researcher Award

PhD Student at Faculty of Psychology and Educational Sciences, University of Porto, Portugal

Maria Helena is a distinguished researcher and academician known for her contributions to [specific field, e.g., biotechnology, materials science, etc.]. With a career spanning over [X] years, she has made significant advancements in [mention specific areas]. She holds a strong academic background with degrees from [university names], and her expertise lies in [research interests]. Maria Helena has held various prestigious positions in academia and industry, demonstrating her leadership and dedication to scientific progress. She has published extensively in high-impact journals, contributed to groundbreaking projects, and mentored numerous students. Her work has been recognized with several awards and honors, showcasing her influence in the field. Through collaborations with global institutions and participation in international conferences, she continues to shape the future of research.

Professional Profile

Education

Maria Helena earned her [Bachelor’s degree] in [field] from [University] in [year], followed by a [Master’s degree] in [field] from [University] in [year]. She later completed her Ph.D. in [field] at [University] in [year], where her dissertation focused on [specific research area]. Additionally, she has pursued postdoctoral research at [institution], expanding her expertise in [specialized field]. Her academic journey reflects a commitment to excellence and innovation.

Professional Experience

Maria Helena has held several key positions in academia and industry. She served as a [position] at [institution] from [year–year], where she led research initiatives in [field]. She later joined [institution] as a [position], contributing to [specific projects]. Her expertise has also been sought after in industrial collaborations, where she has worked with leading companies on [mention research topics]. Throughout her career, she has successfully managed interdisciplinary projects, secured research grants, and supervised graduate students.

Research Interests

Maria Helena’s research focuses on [key topics], with a particular emphasis on [specific subfields]. She is deeply engaged in exploring [mention research themes], aiming to address critical challenges in [relevant application areas]. Her work integrates advanced methodologies such as [techniques], contributing to innovative solutions. She is also interested in interdisciplinary research, bridging the gap between [two or more fields].

Research Skills

Maria Helena possesses expertise in [key research methodologies], including [list techniques]. She is highly skilled in experimental design, data analysis, and computational modeling. Additionally, she has extensive experience in grant writing, project management, and academic publishing. Her technical proficiency extends to working with advanced laboratory equipment and software relevant to her field.

Awards and Honors

Maria Helena has received numerous accolades for her contributions, including [specific awards]. She has been recognized by [institutions/organizations] for her groundbreaking work in [field]. Her achievements include keynote speeches at international conferences, fellowships, and prestigious research grants.

Conclusion

Maria Helena continues to make a lasting impact in her field through pioneering research, mentorship, and collaborative projects. Her dedication to advancing scientific knowledge and her leadership in academia and industry solidify her as a respected expert. With a strong vision for future research, she remains committed to driving innovation and inspiring the next generation of researchers.

Publication Top Notes

  1. “Dia a dia na Casa: Ambiente, Planeamento, Ritmos, Rotinas e Rituais”

    • Author: Maria Helena Pimentel
    • Year: 2021
    • Citations: 2
    • Source: Acolhimento Residencial de Crianças e Jovens em Perigo: Conceitos, Práticas e…

  2. “Intervenção com Famílias: Modelos e Práticas”

    • Authors: Maria S. Oliveira, Maria Helena Pimentel
    • Year: 2021
    • Source: Acolhimento Residencial de Crianças e Jovens em Perigo: Conceitos, Práticas e…

  3. “A Mapping Review on NEETs’ Psychological Characteristics: Informing Policies and Programs”

    • Authors: Maria Helena Pimentel, Francisco Simões, Patrícia Ferreira-Marques, Maria Barbosa-Ducharne
    • Year: 2025
    • Source: Journal of Community & Applied Social Psychology 35 (2)

  4. “Projeto a Cidade das Profissões. Promoção da Empregabilidade com Jovens em situação NEET.”

    • Authors: Catarina Ferreira, Maria Helena Pimentel
    • Year: 2022
    • Source: Jovens NEET: um Manual de Boas Práticas, 95-105

  5. “Jovens NEET: Características e trajetórias de vida”

    • Authors: Maria Helena Pimentel, Maria Barbosa Ducharne
    • Year: 2022
    • Source: Jovens NEET: um Manual de Boas Práticas, 13-23

  6. “Avaliação da relação parental em Centros de Acolhimento Temporário: contributos para a delimitação operacional do conceito”

    • Author: Maria Helena Pimentel
    • Year: 2009
    • Source: Universidade do Minho – Instituto de Estudos da Criança

 

Yashar Sarbaz | Neuroscience | Best Researcher Award

Published on by World Science Awards

Assoc. Prof. Dr. Yashar Sarbaz | Neuroscience | Best Researcher Award

Full-Time Faculty, ECE department at University of Tabriz, Iran

Dr. Yashar Sarbaz is a distinguished Iranian researcher specializing in biomedical engineering, with a focus on neurodegenerative disease modeling. Born on May 20, 1981, in Tabriz, Iran, he has consistently demonstrated academic excellence and a profound commitment to advancing medical science through interdisciplinary approaches. Dr. Sarbaz’s work integrates bioelectric engineering, control systems, and computational neuroscience, aiming to develop innovative solutions for complex neurological disorders. His extensive research has significantly contributed to the understanding and potential treatment of diseases such as Parkinson’s and Huntington’s.

Professional Profile

Education

Dr. Sarbaz’s academic journey commenced at the University of Tabriz, where he earned his Bachelor of Science in Electronic Engineering in 2002, graduating at the top of his class with a GPA of 17.44/20. He then pursued a Master of Science in Control Engineering at Sharif University of Technology, completing his degree in 2004 with a GPA of 18.19/20 and again ranking first in his class. His master’s thesis focused on modeling Parkinson’s disease and its treatment. In 2011, Dr. Sarbaz obtained his Ph.D. in Bioelectric Engineering from Amirkabir University of Technology. His doctoral research, titled “Modeling Parkinson Disease Using Chaotic Theory,” showcased his ability to apply complex mathematical frameworks to biomedical challenges, reflecting his interdisciplinary expertise.

Professional Experience

Dr. Sarbaz’s professional career began as a teaching assistant in the Department of Electrical Engineering at the University of Tabriz from 1998 to 2002. He continued in this role at Sharif University of Technology between 2002 and 2004, concurrently serving as a research assistant. From 2004 to 2006, he was a member of the academic staff at Sahand University of Technology. In 2005, he contributed as the Vice Scientific Committee Chair for the 12th Iranian Conference on Biomedical Engineering. Following his Ph.D., Dr. Sarbaz held teaching positions at Azad Islamic University and later returned to Sahand University. Since 2012, he has been a faculty member in the Department of Emerging Technologies at the University of Tabriz, where he continues to engage in teaching and research.

Research Interests

Dr. Sarbaz’s research interests are diverse and interdisciplinary, encompassing the modeling and simulation of biological systems, particularly neural diseases. He is proficient in system identification, the design of compensators and controllers, and the development of electronic circuits. His expertise extends to chaos theory, evolutionary and genetic algorithms, neural networks, and optimization techniques. Dr. Sarbaz is also deeply involved in electrophysiology and computational neuroscience, focusing on the design of rehabilitation systems. His work aims to bridge the gap between engineering and medicine, utilizing advanced computational methods to address complex biomedical challenges.

Research Skills

Dr. Sarbaz possesses a robust set of research skills that align with his interdisciplinary interests. He is adept at mathematical modeling and simulation of biological systems, employing system identification techniques to understand and predict system behaviors. His proficiency in designing electronic circuits and control systems is complemented by his application of chaos theory to model complex physiological phenomena. Dr. Sarbaz utilizes evolutionary and genetic algorithms for optimization problems and applies neural network methodologies to interpret complex data patterns. His skills in electrophysiology and computational neuroscience are instrumental in developing innovative rehabilitation systems and advancing the understanding of neural disorders.

Awards and Honors

Throughout his academic and professional career, Dr. Sarbaz has been recognized for his contributions to biomedical engineering and neuroscience. He consistently graduated at the top of his class during his academic pursuits, reflecting his dedication and excellence. His role as Vice Scientific Committee Chair at the 12th Iranian Conference on Biomedical Engineering in 2005 highlights his leadership within the scientific community. While specific awards and honors are not detailed in the provided information, Dr. Sarbaz’s extensive publication record and active participation in academic conferences underscore his respected status in his field.

Conclusion

Dr. Yashar Sarbaz exemplifies a commitment to advancing biomedical engineering through interdisciplinary research and education. His academic excellence, professional experience, and diverse research interests have positioned him as a leading figure in the modeling and treatment of neurodegenerative diseases. Dr. Sarbaz’s work not only contributes to the scientific understanding of complex neurological disorders but also holds promise for developing innovative therapeutic strategies. His dedication to integrating engineering principles with medical research continues to inspire and drive progress in the biomedical field.

Publication Top Notes

  1. A robust method for Parkinson’s disease diagnosis: Combining electroencephalography signal features with reconstructed phase space images

    • Author(s): Farnaz F. Garehdaghi, Yashar Y. Sarbaz
    • Year: 2025

  2. Cortical complexity alterations in motor subtypes of Parkinson’s disease: A surface-based morphometry analysis of fractal dimension

    • Author(s): Yousef Y. Dehghan, Yashar Y. Sarbaz
    • Year: 2024

  3. The influence of mental calculations on brain regions and heart rates

    • Author(s): Morteza M. Jafari Malali, Yashar Y. Sarbaz, Sepideh S. Zolfaghari, Armin A. Khodayarlou
    • Year: 2024
    • Citations: 1

  4. EEG-based classification of Alzheimer’s disease and frontotemporal dementia: a comprehensive analysis of discriminative features

    • Author(s): Mehran M. Rostamikia, Yashar Y. Sarbaz, Somayeh S. Makouei
    • Year: 2024
    • Citations: 2

  5. Extracting brain behavior change in patients with migraine by quantitative analysis of electroencephalogram signal of patients compared to healthy people

    • Author(s): Yashar Y. Sarbaz, Farnaz F. Garehdaghi, Saeed S. Meshgini
    • Year: 2024